Paralel Advisors LLC Has $3.08 Million Stock Position in Healthpeak Properties, Inc. $DOC

Paralel Advisors LLC lifted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 25.5% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 144,063 shares of the real estate investment trust’s stock after buying an additional 29,300 shares during the period. Paralel Advisors LLC’s holdings in Healthpeak Properties were worth $3,083,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. New York Life Investment Management LLC increased its stake in Healthpeak Properties by 65.8% during the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock worth $2,510,000 after purchasing an additional 61,952 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its stake in Healthpeak Properties by 176.0% in the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 320,040 shares of the real estate investment trust’s stock valued at $5,146,000 after buying an additional 204,100 shares in the last quarter. Swedbank AB lifted its stake in Healthpeak Properties by 433.4% in the fourth quarter. Swedbank AB now owns 849,215 shares of the real estate investment trust’s stock valued at $13,655,000 after buying an additional 690,000 shares in the last quarter. Nan Fung Trinity HK Ltd. acquired a new position in shares of Healthpeak Properties in the fourth quarter valued at approximately $2,654,000. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Healthpeak Properties by 8.6% in the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after buying an additional 2,438,278 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 2.3%

NYSE:DOC opened at $21.24 on Friday. The company has a market cap of $14.65 billion, a P/E ratio of 60.69, a price-to-earnings-growth ratio of 3.20 and a beta of 1.01. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.95. The business has a 50 day moving average price of $21.37 and a two-hundred day moving average price of $19.00. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. The company had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm’s revenue was up 11.1% compared to the same quarter last year. During the same period last year, the company earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be paid a $0.1017 dividend. This represents a c) annualized dividend and a yield of 5.7%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s payout ratio is presently 348.57%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on DOC shares. Wells Fargo & Company increased their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 15th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Cantor Fitzgerald increased their target price on Healthpeak Properties from $20.00 to $23.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. BMO Capital Markets lifted their price target on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, June 15th. Finally, JPMorgan Chase & Co. lifted their price target on Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, June 24th. Four investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties currently has an average rating of “Hold” and a consensus target price of $21.66.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.